AQUASIL ULTRA UNK

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,07 report with the FDA on 2005-03-17 for AQUASIL ULTRA UNK manufactured by Dentsply Caulk.

Event Text Entries

[21628045] A pt experienced numbing and tingling sensations and later swelling and scalloping of the tongue with lesions after multiple impressions with aquasil ultra monophase and aquasil easy mix putty, indicating a possible allergic reaction to either material or a constituent part. The symptoms resolved without medical or surgical intervention.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2515379-2005-00070
MDR Report Key582328
Report Source05,07
Date Received2005-03-17
Date of Report2005-02-15
Date Mfgr Received2005-02-15
Date Added to Maude2005-03-18
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationDENTIST
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactDR PATRICIA KIHN
Manufacturer Street221 W. PHILA. ST. STE. 60
Manufacturer CityYORK PA 17404
Manufacturer CountryUS
Manufacturer Postal17404
Manufacturer Phone7178457511
Manufacturer G1DENTSPLLY CAULK
Manufacturer Street38 W. CLARKE AVE
Manufacturer CityMILFORD DE 19963
Manufacturer CountryUS
Manufacturer Postal Code19963
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameAQUASIL ULTRA
Generic NameIMPRESSION MATERIAL
Product CodeEBH
Date Received2005-03-17
Model NumberNA
Catalog NumberUNK
Lot NumberUNK
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Implant FlagN
Date Removed*
Device Sequence No1
Device Event Key572170
ManufacturerDENTSPLY CAULK
Manufacturer Address* MILFORD DE * US


Patients

Patient NumberTreatmentOutcomeDate
10 2005-03-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.